Thalamic transcriptome screening in three psychiatric states

Journal of Human Genetics

Volumn 54, Issue 11, 2009, Pages 665-675

  Chu, Tearina T ^a   Liu, Yuexun ^a   Kemether, Eileen ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; LCM; Mediodorsal nucleus; SZ; Thalamus; Transcriptome

Indexed keywords

INITIATION FACTOR 2; MAMMALIAN TARGET OF RAPAMYCIN; PANTOTHENIC ACID; PROTEASOME; PROTEIN KINASE B; SOMATOMEDIN BINDING PROTEIN; TRANSCRIPTOME; VASCULOTROPIN; VITAMIN D RECEPTOR; WNT1 PROTEIN;

ADULT; ARTICLE; BIPOLAR DISORDER; CALCIUM SIGNALING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC SCREENING; HUMAN; HUMAN GENOME; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MAJOR DEPRESSION; MALE; MICROARRAY ANALYSIS; NERVE CELL; ONCOGENE RAS; PREFRONTAL CORTEX; SCHIZOPHRENIA; THALAMUS;

ADULT; AGED; AUTOPSY; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; THALAMUS;

EID: 74049122022     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2009.93     Document Type: Article

References (62)

1. Jones, E. G. The thalamic matrix and thalamocortical synchrony. Trends Neurosci. 24, 595-601 (2001).
2. Johnstone, T., van Reekum, C. M., Urry, H. L., Kalin, N. H. & Davidson, R. J. Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J. Neurosci. 27, 8877-8884 (2007).
3. Bleier, R. Retrograde transsynaptic cellular degeneration in mammillary and ventral tegmental nuclei following limbic decortication in rabbits of various ages. Brain Res. 15, 365-393 (1969).
4. Lehrer, D. S., Christian, B. T., Mantil, J., Murray, A. C., Buchsbaum, B. R., Oakes, T. R. et al. Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia. Am. J. Psychiatry 162, 931-938 (2005).
5. Selemon, L. D., Rajkowska, G. & Goldman-Rakic, P. S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry 52, 805-818. discussion 819-820 (1995).
6. Byne, W., Buchsbaum, M. S., Mattiace, L. A., Hazlett, E. A., Kemether, E., Elhakem, S. L. et al. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am. J. Psychiatry 159, 59-65 (2002).
7. Danos, P., Baumann, B., Kramer, A., Bernstein, H. G., Stauch, R., Krell, D. et al. Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophr. Res. 60, 141-155 (2003).
8. Hazlett, E. A., Buchsbaum, M. S., Kemether, E., Bloom, R., Platholi, J., Brickman, A. M. et al. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am. J. Psychiatry 161, 305-314 (2004).
9. Popken, G. J., Bunney, Jr. W. E , Potkin, S. G. & Jones, E. G. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl Acad. Sci. USA 97, 9276-9280 (2000).
10. Cullen, T. J., Walker, M. A., Parkinson, N., Craven, R., Crow, T. J., Esiri, M. M. et al. A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia. Schizophr. Res. 60, 157-166 (2003).
11. Dorph-Petersen, K. A., Pierri, J. N., Sun, Z., Sampson, A. R. & Lewis, D. A. Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: volume, neuron number, and cell types. J. Comp. Neurol. 472, 449-462 (2004).
12. Young, K. A., Holcomb, L. A., Yazdani, U., Hicks, P. B. & German, D. C. Elevated neuron number in the limbic thalamus in major depression. Am. J. Psychiatry 161, 1270-1277 (2004).
13. Buchsbaum, M. S. & Hazlett, E. A. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr. Bull. 24, 343-364 (1998).
14. Hazlett, E. A., Buchsbaum, M. S., Zhang, J., Newmark, R. E., Glanton, C. F. & Zelmanova, Y. Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating. Neuroimage 42, 1164-1177 (2008).
15. Kemether, E. M., Buchsbaum, M. S., Byne, W., Hazlett, E. A., Haznedar, M., Brickman, A. M. et al. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch. Gen. Psychiatry 60, 983-991 (2003).
16. Mitelman, S. A., Byne, W., Kemether, E. M., Hazlett, E. A. & Buchsbaum, M. S. Metabolic disconnection between the mediodorsal nucleus of the thalamus and cortical Brodmann's areas of the left hemisphere in schizophrenia. Am. J. Psychiatry 162, 1733-1735 (2005).
17. Olney, J. W. & Farber, N. B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52, 998-1007 (1995).
18. Goff, D. C. & Coyle, J. T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry 158, 1367-1377 (2001).
19. Lewis, D. A. & Moghaddam, B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch. Neurol. 63, 1372-1376 (2006).
20. Byne, W., Hazlett, E. A., Buchsbaum, M. S. & Kemether, E. The thalamus and schizophrenia: current status of research. Acta Neuropathol. 117, 347-368 (2008).
21. Torrey, E. F., Webster, M., Knable, M., Johnston, N. & Yolken, R. H. The stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 44, 151-155 (2000).
22. Ray, J. P. & Price, J. L. The organization of projections from the mediodorsal nucleus of the thalamus to orbital and medial prefrontal cortex in macaque monkeys. J. Comp. Neurol. 337, 1-31 (1993).
23. Bleier, R., Byne, W. & Siggelkow, I. Cytoarchitectonic sexual dimorphisms of the medial preoptic and anterior hypothalamic areas in guinea pig, rat, hamster, and mouse. J.Comp. Neurol. 212, 118-130 (1982).
24. Mufson, E. J., Counts, S. E., Che, S. & Ginsberg, S. D. Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease. Prog. Brain Res. 158, 197-222 (2006).
25. Perez-Manso, M., Barroso-Chinea, P., Aymerich, M. S. & Lanciego, J. L. 'Functional' neuroanatomical tract tracing: analysis of changes in gene expression of brain circuits of interest. Brain Res. 1072, 91-98 (2006).
26. Murray, K. D., Choudary, P. V. & Jones, E. G. Nucleus- and cell-specific gene expression in monkey thalamus. Proc. Natl Acad. Sci. USA 104, 1989-1994 (2007).
27. Irizarry, R. A., Bolstad, B. M., Collin, F., Cope, L. M., Hobbs, B. & Speed, T. P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15 (2003).
28. Vawter, M. P., Tomita, H., Meng, F., Bolstad, B., Li, J., Evans, S. et al. Mitochondrialrelated gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol. Psychiatry 11: 615 663-679 (2006).
29. Tomita, H., Vawter, M. P., Walsh, D. M., Evans, S. J., Choudary, P. V., Li, J. et al. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol. Psychiatry 55, 346-352 (2004).
30. Huang, da W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).
31. Hosack, D. A., Dennis, Jr G., Sherman, B. T., Lane, H. C. & Lempicki, R. A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4, R70 (2003).
32. Dennis, Jr G, Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C. et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, P3 (2003).
33. Steffek, A. E., McCullumsmith, R. E., Haroutunian, V. & Meador-Woodruff, J. H. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr. Res. 103, 71-82 (2008).
34. Altar, C. A., Hunt, R. A., Jurata, L. W., Webster, M. J., Derby, E., Gallagher, P. et al. Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells. Biol. Psychiatry 64, 1077-1087 (2008).
35. Altar, C. A., Jurata, L. W., Charles, V., Lemire, A., Liu, P., Bukhman, Y. et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol. Psychiatry 58, 85-96 (2005).
36. Zhao, Z., Ksiezak-Reding, H., Riggio, S., Haroutunian, V. & Pasinetti, G. M. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr. Res. 84, 1-14 (2006).
37. Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M. & Gogos, J. A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 36, 131-137 (2004).
38. Schieke, S. M., Phillips, D., McCoy, Jr J. P, Aponte, A. M., Shen, R. F., Balaban, R. S. et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem. 281, 27643-27652 (2006).
39. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C., Marangoni, S., Novello, J. C. et al. Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J. Neural Transm. 116, 275-289 (2009).
40. Dai, Y. S., Xu, J. & Molkentin, J. D. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. Mol. Cell. Biol. 25, 9936-9948 (2005).
41. Parrilla-Castellar, E. R., Arlander, S. J. & Karnitz, L. Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex. DNA Repair. (Amst) 3, 1009-1014 (2004).
42. Occhi, G., Rampazzo, A., Beffagna, G. & Antonio Danieli, G. Identification and characterization of heart-specific splicing of human neurexin 3 mRNA (NRXN3). Biochem. Biophys. Res. Commun. 298, 151-155 (2002).
43. Dean, C. & Dresbach, T. Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Trends Neurosci. 29, 21-29 (2006).
44. Graf, E. R., Kang, Y., Hauner, A. M. & Craig, A. M. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 beta LNS domain. J. Neurosci. 26, 4256-4265 (2006).
45. Graf, E. R., Zhang, X., Jin, S. X., Linhoff, M. W. & Craig, A. M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 119, 1013-1026 (2004).
46. Missler, M., Fernandez-Chacon, R. & Sudhof, T. C. The making of neurexins. J. Neurochem. 71, 1339-1347 (1998).
47. Ushkaryov, Y. A., Petrenko, A. G., Geppert, M. & Sudhof, T. C. Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science 257, 50-56 (1992).
48. Nam, C. I. & Chen, L. Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter. Proc. Natl Acad. Sci. USA 102, 6137-6142 (2005).
49. Hishimoto, A., Liu, Q. R., Drgon, T., Pletnikova, O., Walther, D., Zhu, X. G. et al. Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms. Hum. Mol. Genet. 16, 2880-2891 (2007).
50. Bierut, L. J., Madden, P. A., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O. F. et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 16, 24-35 (2007).
51. Lachman, H. M., Fann, C. S., Bartzis, M., Evgrafov, O. V., Rosenthal, R. N., Nunes, E. V. et al. Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum. Mol. Genet. 16, 1327-1334 (2007).
52. Mirnics, K., Levitt, P. & Lewis, D. A. Critical appraisal of DNA microarrays in psychiatric genomics. Biol. Psychiatry 60, 163-176 (2006).
53. Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A. & Levitt, P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53-67 (2000).
54. Iwamoto, K., Bundo, M. & Kato, T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 14, 241-253 (2005).
55. Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J. T., Griffin, J. L. et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 9, 684-697. 643 (2004). (Pubitemid 38932173)
56. Li, J. Z., Vawter, M. P., Walsh, D. M., Tomita, H., Evans, S. J., Choudary, P. V. et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum. Mol. Genet. 13, 609-616 (2004).
57. Eastwood, S. L. & Harrison, P. J. Decreased mRNA expression of netrin-G1 and netrin- G2 in the temporal lobe in schizophrenia and bipolar disorder. Neuropsychopharmacology 33, 933-945 (2008).
58. Risch, N. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet. Epidemiol. 7, 3-16. discussion 17-45 (1990).
59. Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M. & Abderrahim, H. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc. Natl Acad. Sci. USA 99, 13675-13680 (2002).
60. O'Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V. et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 40, 1053-1055 (2008).
61. Brazma, A. & Vilo, J. Gene expression data analysis. FEBS Lett. 480, 17-24 (2000).
62. Sobell, J. L., Mikesell, M. J. & McMurray, C. T. Genetics and etiopathophysiology of schizophrenia. Mayo Clin. Proc. 77, 1068-1082 (2002).